Translating Population Difference: The Use and Re-Use of Genetic Ancestry in Brazilian Cancer Genetics
Author:
Open Access
- 9 October 2015
- journal article
- research article
- Published by Taylor & Francis in Medical Anthropology
- Vol. 35 (1) , 58-72
Abstract
In the past ten years, there has been an expansion of scientific interest in population genetics linked to both understanding histories of human migration and the way that population difference and diversity may account for and/or be implicated in health and disease. In this article, I examine how particular aspects of a globalizing research agenda related to population differences and genetic ancestry are taken up in locally variant ways in the nascent field of Brazilian cancer genetics. Drawing on a broad range of ethnographic data from clinical and nonclinical contexts in the south of Brazil, I examine the ambiguities that attention to genetic ancestry generates, so revealing the disjunctured and diverse ways a global research agenda increasingly orientated to questions of population difference and genetic ancestry is being used and reused.Keywords
Funding Information
- Wellcome Trust (WT084128MA)
This publication has 35 references indexed in Scilit:
- Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndromeHereditary Cancer in Clinical Practice, 2011
- Racial taxonomy in genomicsSocial Science & Medicine, 2011
- Primary appendiceal mucinous adenocarcinoma in two first-degree relatives: case report and reviewHereditary Cancer in Clinical Practice, 2011
- On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populationsEuropean Journal of Human Genetics, 2010
- Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and controlEPMA Journal, 2010
- Detailed haplotype analysis at theTP53locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effectHuman Mutation, 2009
- Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern BrazilGenetics and Molecular Biology, 2009
- Pharmacogenomics and the Challenge of Health DisparitiesPublic Health Genomics, 2009
- Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from BrazilBreast Cancer Research and Treatment, 2006
- An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinomaProceedings of the National Academy of Sciences, 2001